Perioperative bleeding continues to be a serious problem during and after surgery, leading to increased mortality and morbidity. Non-vascular sources of haemostatic perioperative bleeding often result from a bleeding problem that has gone undiscovered, from the specifics of the surgery itself, or acquired coagulation abnormalities due to haemorrhage, hemodilution, or the administration of haemostatic factors. Allogeneic blood product delivery, pharmacologic medicines, and the growing use of pure or recombinant haemostatic factors are all considered conventional treatment techniques in the management of bleeding patients. Trauma and sophisticated surgical operations, such as heart surgery and liver transplantation, cause a cascade of haemostatic alterations in the perioperative period. Tranexamic acid, desmopressin, fibrinogen, and prothrombin complex concentrates are some of the newer methods used for both the prevention and treatment of perioperative bleeding. More in-depth evaluation of targeted treatment for haemostasis is now possible because to point-of-care testing using thromboelastography, rotational thromboelastometry, and platelet function tests. Better management, less use of allogeneic blood products, and fewer transfusion-related complications may be achieved by multimodal, and strategic approaches. The goal of this effort is to alleviate the difficulty of controlling bleeding in surgical patients. Research priorities include, but are not limited to, preventing hypotension, sustaining appropriate tissue perfusion and oxygenation, and preventing bleeding.